Viewing Study NCT03964532


Ignite Creation Date: 2025-12-24 @ 9:55 PM
Ignite Modification Date: 2025-12-25 @ 7:33 PM
Study NCT ID: NCT03964532
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-21
First Post: 2019-04-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer
Sponsor: Georgetown University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module